Physician profile
Tamara E Torres
NPI 1962928390
$3,861.79
in general payments reported to CMS, 2019-2025
11 companies · $54.90 in 2025
The $54.90 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $369 · 2022: $723 · 2023: $1,883 · 2024: $831 · 2025: $54.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,934 · Travel and Lodging: $836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,933.59 |
| Travel and Lodging | $835.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,839.67 | 2021-2025 | Watchman Access System, Watchman Flx, General - Brady |
| Abbott Laboratories | $438.96 | 2022-2023 | Mitraclip |
| E.R. Squibb & Sons, L.L.C. | $357.87 | 2022-2024 | Camzyos |
| Kestra Medical Technology Services, INC. | $301.82 | 2023-2024 | Assure Wcd |
| Amgen INC. | $283.79 | 2021-2023 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $164.15 | 2021-2025 | Lifevest |
| Scpharmaceuticals INC. | $133.63 | 2024 | |
| Atricure, INC. | $124.34 | 2022 | |
| Impulse Dynamics (USA) INC. | $111.83 | 2024 | Optimizer |
| Janssen Pharmaceuticals, INC | $67.12 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $38.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.